Clinical Trials Directory

Trials / Unknown

UnknownNCT02022579

DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer

A Multi-Center Study Evaluating the Utility of Diffusion Weighted Imaging for Detection and Diagnosis of Breast Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
American College of Radiology Imaging Network · Network
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

A type of magnetic resonance imaging called diffusion weighted imaging (DWI) will be tested to define cancerous from non-cancerous lesions in the breast.

Detailed description

For this study, the investigators plan to evaluate DWI scans performed in women with breast lesions identified by conventional breast MRI. The investigators will determine whether an ADC threshold can be defined for distinguishing benign and malignant lesions on DWI, assess the difference in ADC cutoffs for mass and non-mass lesions, and investigate the potential improvement in accuracy using techniques such as nonzero minimum b-value (to remove perfusion effects in the ADC measures) and normalized ADC measures (to account for variations in water content and other factors).

Conditions

Interventions

TypeNameDescription
PROCEDUREDCE-MRI and DWIDCE-MRI defined lesion(s) compared with biopsy results or 1-year follow up

Timeline

Start date
2014-01-01
Primary completion
2018-11-01
Completion
2019-03-01
First posted
2013-12-30
Last updated
2018-10-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02022579. Inclusion in this directory is not an endorsement.